Efficacy and safety of azathioprine during remission of immune-mediated thrombotic thrombocytopenic purpura
- PMID: 35772164
- PMCID: PMC9631697
- DOI: 10.1182/bloodadvances.2022007632
Efficacy and safety of azathioprine during remission of immune-mediated thrombotic thrombocytopenic purpura
References
-
- George JN, Nester CM. Syndromes of thrombotic microangiopathy. N Engl J Med. 2014;371(7):654-666. - PubMed
-
- Verbij FC, Fijnheer R, Voorberg J, Sorvillo N. Acquired TTP: ADAMTS13 meets the immune system. Blood Rev. 2014;28(6):227-234. - PubMed
-
- Scully M, Yarranton H, Liesner R, et al. Regional UK TTP registry: correlation with laboratory ADAMTS 13 analysis and clinical features. Br J Haematol. 2008;142(5):819-826. - PubMed
-
- Reese JA, Muthurajah DS, Kremer Hovinga JA, Vesely SK, Terrell DR, George JN. Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical features. Pediatr Blood Cancer. 2013;60(10): 1676-1682. - PubMed
